Skip to main content
Equibles

Rubric Capital Management LP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1687509 NEW YORK, NY
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$527,681,000
+$68,351,000 QoQ
Shares Held
15,575,000
+2.1% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
4.84%
of 13F equity value
Holder Rank
#12
of 675 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Rubric Capital Management LP holds $1,630,260,569 across 8 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (32.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 34,168,743 $542,599,638
2 TEVA
Teva Pharmaceutical Industries Ltd
This page 		15,575,000 $527,681,000
3 KNSA
Kiniksa Pharmaceuticals International, plc
 3,999,800 $255,787,210
4 AMRX
Amneal Pharmaceuticals, Inc.
 10,168,660 $176,019,504
5 ALVO
Alvotech
 15,677,093 $57,848,473
6 COLL
Collegium Pharmaceutical, Inc
 1,279,611 $46,321,918
7 ANIP
Ani Pharmaceuticals Inc
 258,131 $21,368,084
8 TXMD
TherapeuticsMD, Inc.
 1,192,191 $2,634,742

All Filings in TEVA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $527,681,000 15,575,000
2026-03-31 $459,330,000 15,250,000
2025-12-31 $666,505,467 21,355,510
2025-09-30 $497,930,000 24,650,000
2025-06-30 $435,760,000 26,000,000
2025-03-31 $392,703,500 25,550,000
2024-12-31 $374,680,000 17,000,000
2024-09-30 $288,419,073 16,005,498
2024-06-30 $280,503,291 17,261,741
2024-03-31 $249,317,886 17,669,588
2023-12-31 $190,285,714 18,226,601
2023-09-30 $193,800,000 19,000,000
2023-06-30 $140,949,265 18,718,362
2023-03-31 $39,823,283 4,499,806